Implementing a national programme of pathogen genomics for public health: the Australian Pathogen Genomics Program (AusPathoGen).
Webb, JR
Andersson, P
Sim, E
Zahedi, A
Donald, A
Hoang, T
Watt, AE
Agius, JE
Donato, CM
Cummins, ML
Zulfiqar, T
Nghiem, S
Lin, C
Menouhos, D
Leong, LEX
Baird, R
Kennedy, K
Cooley, L
Speers, D
Lim, CK
de Ligt, J
Ferdinand, A
Glass, K
Kirk, MD
Djordjevic, SP
Sloggett, C
Horan, K
Seemann, T
Sintchenko, V
Jennison, AV
Howden, BP
AusPathoGen Program partners,
- Publisher:
- Elsevier
- Publication Type:
- Journal Article
- Citation:
- Lancet Microbe, 2024, pp. 100969
- Issue Date:
- 2024-10-07
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
| Field | Value | Language |
|---|---|---|
| dc.contributor.author | Webb, JR | |
| dc.contributor.author | Andersson, P | |
| dc.contributor.author | Sim, E | |
| dc.contributor.author | Zahedi, A | |
| dc.contributor.author | Donald, A | |
| dc.contributor.author | Hoang, T | |
| dc.contributor.author | Watt, AE | |
| dc.contributor.author | Agius, JE | |
| dc.contributor.author | Donato, CM | |
| dc.contributor.author | Cummins, ML | |
| dc.contributor.author | Zulfiqar, T | |
| dc.contributor.author | Nghiem, S | |
| dc.contributor.author | Lin, C | |
| dc.contributor.author | Menouhos, D | |
| dc.contributor.author | Leong, LEX | |
| dc.contributor.author | Baird, R | |
| dc.contributor.author | Kennedy, K | |
| dc.contributor.author | Cooley, L | |
| dc.contributor.author | Speers, D | |
| dc.contributor.author | Lim, CK | |
| dc.contributor.author | de Ligt, J | |
| dc.contributor.author | Ferdinand, A | |
| dc.contributor.author | Glass, K | |
| dc.contributor.author | Kirk, MD | |
| dc.contributor.author | Djordjevic, SP | |
| dc.contributor.author | Sloggett, C | |
| dc.contributor.author | Horan, K | |
| dc.contributor.author | Seemann, T | |
| dc.contributor.author | Sintchenko, V | |
| dc.contributor.author | Jennison, AV | |
| dc.contributor.author | Howden, BP | |
| dc.contributor.author | AusPathoGen Program partners, | |
| dc.date.accessioned | 2024-12-06T05:55:44Z | |
| dc.date.available | 2024-07-31 | |
| dc.date.available | 2024-12-06T05:55:44Z | |
| dc.date.issued | 2024-10-07 | |
| dc.identifier.citation | Lancet Microbe, 2024, pp. 100969 | |
| dc.identifier.issn | 2666-5247 | |
| dc.identifier.issn | 2666-5247 | |
| dc.identifier.uri | http://hdl.handle.net/10453/182403 | |
| dc.description.abstract | Delivering large-scale routine pathogen genomics surveillance for public health is of considerable interest, although translational research models that promote national-level implementation are not well defined. We describe the development and deployment of the Australian Pathogen Genomics Program (AusPathoGen), a comprehensive national partnership between academia, public health laboratories, and public health agencies that commenced in January, 2021. Successfully establishing and delivering a national programme requires inclusive and transparent collaboration between stakeholders, defined and clear focus on public health priorities, and support for strengthening national genomics capacity. Major enablers for delivering such a programme include technical solutions for data integration and analysis, such as the genomics surveillance platform AusTrakka, standard bioinformatic analysis methods, and national ethics and data sharing agreements that promote nationally integrated surveillance systems. Training of public health officials to interpret and act on genomic data is crucial, and evaluation and cost-effectiveness programmes will provide a benchmark and evidence for sustainable investment in genomics nationally and globally. | |
| dc.format | Print-Electronic | |
| dc.language | eng | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | Lancet Microbe | |
| dc.relation.isbasedon | 10.1016/j.lanmic.2024.100969 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject.classification | 3107 Microbiology | |
| dc.subject.classification | 3204 Immunology | |
| dc.subject.classification | 3207 Medical microbiology | |
| dc.title | Implementing a national programme of pathogen genomics for public health: the Australian Pathogen Genomics Program (AusPathoGen). | |
| dc.type | Journal Article | |
| utslib.location.activity | England | |
| pubs.organisational-group | University of Technology Sydney | |
| pubs.organisational-group | University of Technology Sydney/Faculty of Science | |
| pubs.organisational-group | University of Technology Sydney/UTS Groups | |
| pubs.organisational-group | University of Technology Sydney/UTS Groups/Australian Institute for Microbiology & Infection (AIMI) | |
| utslib.copyright.status | open_access | * |
| dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.date.updated | 2024-12-06T05:55:42Z | |
| pubs.publication-status | Published online |
Abstract:
Delivering large-scale routine pathogen genomics surveillance for public health is of considerable interest, although translational research models that promote national-level implementation are not well defined. We describe the development and deployment of the Australian Pathogen Genomics Program (AusPathoGen), a comprehensive national partnership between academia, public health laboratories, and public health agencies that commenced in January, 2021. Successfully establishing and delivering a national programme requires inclusive and transparent collaboration between stakeholders, defined and clear focus on public health priorities, and support for strengthening national genomics capacity. Major enablers for delivering such a programme include technical solutions for data integration and analysis, such as the genomics surveillance platform AusTrakka, standard bioinformatic analysis methods, and national ethics and data sharing agreements that promote nationally integrated surveillance systems. Training of public health officials to interpret and act on genomic data is crucial, and evaluation and cost-effectiveness programmes will provide a benchmark and evidence for sustainable investment in genomics nationally and globally.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph